1
Orphan Designations
0 approved, 1 designated
0
FDA Approvals
2
Active Trials
200 recruiting
3
Rare Diseases
across 4 areas
0
News (30d)
Quiet
Telix Pharmaceuticals (Innovations) Pty Ltd. is a company with 1 orphan drug designation across 3 rare diseases. Active clinical trials in 2 indications.
Disease-by-disease pipeline progression from orphan designation through clinical trials to FDA approval.
Source: FDA Orphan Drug Designations, ClinicalTrials.gov, Drugs@FDA
| Disease | Drug(s) | Stage |
|---|---|---|
| brain neoplasm | - | Des.TrialAppr. |
| osteosarcoma | Samarium (Sm-153) chelate of DOTMP (1,4,7,10-tetraazacyclododecane-1,4,7,10-tetra(methylenephophonate)) | Des.TrialAppr. |
| sarcoma | - | Des.TrialAppr. |
0% of portfolio targets high unmet need diseases
24
overlap in 2+ diseases
0/3
candidate diseases
0
avg importance: 0
0
affecting portfolio
0% of portfolio targets high unmet need diseases
24
overlap in 2+ diseases
0/3
candidate diseases
0
avg importance: 0
0
affecting portfolio